vs
Side-by-side financial comparison of Bank of America (BAC) and HCA Healthcare (HCA). Click either name above to swap in a different company.
Bank of America is the larger business by last-quarter revenue ($30.3B vs $19.1B, roughly 1.6× HCA Healthcare). Bank of America runs the higher net margin — 28.4% vs 9.7%, a 18.6% gap on every dollar of revenue. Over the past eight quarters, Bank of America's revenue compounded faster (8.3% CAGR vs 4.5%).
The Bank of America Corporation is an American multinational investment bank and financial services holding company headquartered at the Bank of America Corporate Center in Charlotte, North Carolina, with investment banking and auxiliary headquarters in Manhattan. The bank was founded by the merger of NationsBank and Bank of America in 1998.
HCA Healthcare, Inc. is an American global for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owned and operated 186 hospitals and approximately 2,400 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 20 states and the United Kingdom.
BAC vs HCA — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $30.3B | $19.1B |
| Net Profit | $8.6B | $1.9B |
| Gross Margin | — | — |
| Operating Margin | — | — |
| Net Margin | 28.4% | 9.7% |
| Revenue YoY | — | 4.3% |
| Net Profit YoY | 16.6% | 1.8% |
| EPS (diluted) | $1.11 | $7.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $30.3B | $19.1B | ||
| Q4 25 | $31.2B | $19.5B | ||
| Q3 25 | $28.1B | $19.2B | ||
| Q2 25 | $26.5B | $18.6B | ||
| Q1 25 | $27.4B | $18.3B | ||
| Q4 24 | — | $18.3B | ||
| Q3 24 | $25.3B | $17.5B | ||
| Q2 24 | $25.4B | $17.5B |
| Q1 26 | $8.6B | $1.9B | ||
| Q4 25 | $7.5B | $1.9B | ||
| Q3 25 | $8.5B | $1.6B | ||
| Q2 25 | $7.1B | $1.7B | ||
| Q1 25 | $7.4B | $1.6B | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | $6.9B | $1.3B | ||
| Q2 24 | $6.9B | $1.5B |
| Q1 26 | — | — | ||
| Q4 25 | 39.9% | 13.7% | ||
| Q3 25 | 33.7% | 12.6% | ||
| Q2 25 | 29.1% | 13.0% | ||
| Q1 25 | 29.7% | 12.7% | ||
| Q4 24 | — | 11.7% | ||
| Q3 24 | 28.9% | 10.9% | ||
| Q2 24 | 29.8% | 12.8% |
| Q1 26 | 28.4% | 9.7% | ||
| Q4 25 | 24.1% | 9.6% | ||
| Q3 25 | 30.2% | 8.6% | ||
| Q2 25 | 26.9% | 8.9% | ||
| Q1 25 | 27.0% | 8.8% | ||
| Q4 24 | — | 7.9% | ||
| Q3 24 | 27.2% | 7.3% | ||
| Q2 24 | 27.2% | 8.4% |
| Q1 26 | $1.11 | $7.15 | ||
| Q4 25 | $0.96 | $8.09 | ||
| Q3 25 | $1.06 | $6.96 | ||
| Q2 25 | $0.89 | $6.83 | ||
| Q1 25 | $0.90 | $6.45 | ||
| Q4 24 | — | $5.66 | ||
| Q3 24 | $0.81 | $4.88 | ||
| Q2 24 | $0.83 | $5.53 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $242.5B | $940.0M |
| Total DebtLower is stronger | $9.6B | — |
| Stockholders' EquityBook value | $300.7B | — |
| Total Assets | $3496.2B | $19.3B |
| Debt / EquityLower = less leverage | 0.03× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $242.5B | $940.0M | ||
| Q4 25 | — | $1.0B | ||
| Q3 25 | — | $997.0M | ||
| Q2 25 | — | $939.0M | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $1.9B | ||
| Q3 24 | — | $2.9B | ||
| Q2 24 | — | $831.0M |
| Q1 26 | $9.6B | — | ||
| Q4 25 | $317.8B | $44.3B | ||
| Q3 25 | $311.5B | $42.6B | ||
| Q2 25 | $313.4B | $42.7B | ||
| Q1 25 | $304.1B | $44.6B | ||
| Q4 24 | — | $43.0B | ||
| Q3 24 | $296.9B | $43.0B | ||
| Q2 24 | $290.5B | $40.9B |
| Q1 26 | $300.7B | — | ||
| Q4 25 | $303.2B | $-6.0B | ||
| Q3 25 | $304.2B | $-5.3B | ||
| Q2 25 | $299.6B | $-4.4B | ||
| Q1 25 | $295.6B | $-3.5B | ||
| Q4 24 | — | $-2.5B | ||
| Q3 24 | $296.5B | $-2.2B | ||
| Q2 24 | $293.9B | $-1.6B |
| Q1 26 | $3496.2B | $19.3B | ||
| Q4 25 | $3411.7B | $60.7B | ||
| Q3 25 | $3403.7B | $59.7B | ||
| Q2 25 | $3441.1B | $59.5B | ||
| Q1 25 | $3349.4B | $59.8B | ||
| Q4 24 | — | $59.5B | ||
| Q3 24 | $3324.3B | $59.5B | ||
| Q2 24 | $3258.0B | $57.4B |
| Q1 26 | 0.03× | — | ||
| Q4 25 | 1.05× | — | ||
| Q3 25 | 1.02× | — | ||
| Q2 25 | 1.05× | — | ||
| Q1 25 | 1.03× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.00× | — | ||
| Q2 24 | 0.99× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $2.0B |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 1.08× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $2.0B | ||
| Q4 25 | $-22.9B | $2.4B | ||
| Q3 25 | $46.9B | $4.4B | ||
| Q2 25 | $-9.1B | $4.2B | ||
| Q1 25 | $-2.2B | $1.7B | ||
| Q4 24 | — | $2.6B | ||
| Q3 24 | — | $3.5B | ||
| Q2 24 | — | $2.0B |
| Q1 26 | — | — | ||
| Q4 25 | — | $870.0M | ||
| Q3 25 | — | $3.1B | ||
| Q2 25 | — | $3.0B | ||
| Q1 25 | — | $660.0M | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $2.3B | ||
| Q2 24 | — | $690.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 4.5% | ||
| Q3 25 | — | 16.3% | ||
| Q2 25 | — | 16.3% | ||
| Q1 25 | — | 3.6% | ||
| Q4 24 | — | 7.0% | ||
| Q3 24 | — | 13.3% | ||
| Q2 24 | — | 3.9% |
| Q1 26 | — | — | ||
| Q4 25 | — | 7.6% | ||
| Q3 25 | — | 6.7% | ||
| Q2 25 | — | 6.3% | ||
| Q1 25 | — | 5.4% | ||
| Q4 24 | — | 7.0% | ||
| Q3 24 | — | 6.8% | ||
| Q2 24 | — | 7.3% |
| Q1 26 | — | 1.08× | ||
| Q4 25 | -3.05× | 1.26× | ||
| Q3 25 | 5.53× | 2.69× | ||
| Q2 25 | -1.28× | 2.55× | ||
| Q1 25 | -0.30× | 1.03× | ||
| Q4 24 | — | 1.78× | ||
| Q3 24 | — | 2.77× | ||
| Q2 24 | — | 1.35× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BAC
| Net Interest Income | $15.7B | 52% |
| Noninterest Income | $14.5B | 48% |
HCA
Segment breakdown not available.
